Financial intelligence for Asia's healthcare markets
Remember me:


Singapore-based digital healthcare platform MyDoc has signed a deal with Hanoi-headquartered Baoviet Group Insurance to offer a cashless digitally integrated clinic service to its health insurance policyholders.
Interventional medical products provider Peijia Medical Co has raised $100 million in a Series C funding round led by its existing investor, venture capital firm Matrix Partners China.
English-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has announced three large-scale initiatives in China to advance global research and development for new medicines.
Global healthcare company MORE Health has agreed a collaboration with Japan’s Integrity Healthcare, giving international patients access to Integrity Healthcare’s physicians and services.
The Malaysia Healthcare Travel Council says the country’s hospital receipts will be in excess of 2 billion ringgit next year, fuelled by international healthcare tourists expected to number around two million.
The medical health tourism industry in Malaysia could be affected if the government introduces the medicine price control mechanism for private healthcare operators.
Hong Kong-headquartered SinoMab BioScience is looking to raise HK$1.75 billion ($223 million) from an initial public offering.
Fountain Medical Development, a Chinese clinical-stage contract research organisation offering services to pharmaceutical and medical device companies, has raised $62 million in Series D funding.


L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Sumit Sharma and Matt Zafra, head and principal of health & life sciences, Asia Pacific at Oliver Wyman, look at what we can expect in 2019.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.

HealthInvestor Asia twitter feed

Latest analysis

Shifting sands

Fabio La Mola L.E.K. Consulting's Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes - creating significant opportunities for investors in the region.

Read the full feature here

Free trial

HealthInvestor UK